Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ViaDerma Inc VDRM

Healthcare
ViaDerma, Inc. is a specialty pharmaceutical company engaged in bringing new products to market and licensing its transdermal drug delivery technology solutions. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. In addition to licensing its proprietary transdermal technologies, its lead product, Vitastem, is available for treating... see more

Recent & Breaking News (OTCPK:VDRM)

ViaDerma, Inc., to Initiate Upcoming Field Trial of Comparison for Onychomycosis

GlobeNewswire March 2, 2015

ViaDerma, Inc. Announces Preston Richards to Join Advisory Board

GlobeNewswire January 22, 2015

ViaDerma, Inc. Launches New Website

GlobeNewswire January 13, 2015

TetraStem(TM) Antibiotic Continues to Demonstrate Treatment Success Leading Management to Explore Partnerships With Big Pharmaceutical Companies

GlobeNewswire December 9, 2014

ViaDerma, Inc. Lead Product TetraStem Shows Promise in Treating Acne

GlobeNewswire November 21, 2014

ViaDerma, Inc. Appoints Dr. Andrew Berman as Medical Director of Advisory Board

GlobeNewswire November 13, 2014

TetraStem, Lead Product of ViaDerma, Inc., Hopes to Slow Rates of Diabetic Amputations

GlobeNewswire November 7, 2014

These Small-Cap Marijuana Stocks are in Play Next Week

Accesswire October 31, 2014

ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA

PR Newswire October 30, 2014

ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015

PR Newswire October 29, 2014

ViaDerma, Inc. Announces Strategic Partnership With The Brewer Group

PR Newswire August 5, 2014